C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/113 (2010.01) A61K 31/7088 (2006.01) C07H 21/04 (2006.01) C12N 9/12 (2006.01) C12N 15/54 (2006.01)
Patent
CA 2590619
The invention provides for antisense oligonucleotides that hybridize to casein kinase 2 nucleic acid sequences and methods of using such antisense oligonucleotides to inhibit expression of casein kinase 2 and reduce the size of solid tumors.
L'invention concerne des oligonucléotides antisens s'hybridant à des séquences d'acides nucléiques de caséine kinase 2 ainsi que des méthodes d'utilisation de ces oligonucléotides antisens pour inhiber l'expression de la caséine kinase 2 et réduire la taille de tumeurs solides.
Ahmed Khalil
Davis Alan
Slaton Joel W.
Sloper Dan
Unger Gretchen M.
Gowling Lafleur Henderson Llp
Regents Of The University Of Minnesota
LandOfFree
Casein kinase 2 antisense therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Casein kinase 2 antisense therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Casein kinase 2 antisense therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1636568